Related Experiment Video
Updated: Mar 31, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Tumor suppressor ASXL1 is essential for the activation of INK4B expression in response to oncogene activity and
Xudong Wu1,2,3, Ida Holst Bekker-Jensen2,3, Jesper Christensen2,3
1Department of Cell Biology, Tianjin Medical University, Qixiangtai Road 22, Tianjin 300070, China.
Abstract:
ASXL1 mutations are frequently found in hematological tumors, and loss of Asxl1 promotes myeloid transformation in mice. Here we present data supporting a role for an ASXL1-BAP1 complex in the deubiquitylation of mono-ubiquitylated lysine 119 on Histone H2A (H2AK119ub1) in vivo. The Polycomb group proteins control the expression of the INK4B-ARF-INK4A locus during normal development, in part through catalyzing mono-ubiquitylation of H2AK119. Since the activation of the locus INK4B-ARF-INK4A plays a fail-safe mechanism protecting against tumorigenesis, we investigated whether ASXL1-dependent H2A deubiquitylation plays a role in its activation. Interestingly, we found that ASXL1 is specifically required for the increased expression of p15(INK4B) in response to both oncogenic signaling and extrinsic anti-proliferative signals. Since we found that ASXL1 and BAP1 both are enriched at the INK4B locus, our results suggest that activation of the INK4B locus requires ASXL1/BAP1-mediated deubiquitylation of H2AK119ub1. Consistently, our results show that ASXL1 mutations are associated with lower expression levels of p15(INK4B) and a proliferative advantage of hematopoietic progenitors in primary bone marrow cells, and that depletion of ASXL1 in multiple cell lines results in resistance to growth inhibitory signals. Taken together, this study links ASXL1-mediated H2A deubiquitylation and transcriptional activation of INK4B expression to its tumor suppressor functions.
Insights
Mutations in ASXL1 are linked to hematological tumors. This study reveals ASXL1-BAP1 complex deubiquitylation of Histone H2A is crucial for INK4B gene activation, suppressing tumor formation.
Area of Science:
- Epigenetics
- Molecular Biology
- Cancer Biology
Background:
- ASXL1 mutations are common in hematological tumors.
- Loss of Asxl1 function promotes myeloid transformation in mice.
- Polycomb group proteins regulate gene expression via Histone H2A ubiquitylation.
Purpose of the Study:
- Investigate the role of ASXL1-BAP1 complex in Histone H2A deubiquitylation.
- Determine the impact of ASXL1-dependent deubiquitylation on the INK4B-ARF-INK4A locus.
- Elucidate the tumor suppressor function of ASXL1 in hematopoiesis.
Main Methods:
- In vivo studies of ASXL1-BAP1 complex function.
- Analysis of Histone H2A (H2AK119ub1) deubiquitylation.
- Gene expression analysis of the INK4B-ARF-INK4A locus.
- Assessment of ASXL1 depletion effects on cell proliferation and growth inhibition.
Main Results:
- ASXL1-BAP1 complex mediates deubiquitylation of H2AK119ub1.
- ASXL1 is essential for p15(INK4B) expression in response to oncogenic and anti-proliferative signals.
- ASXL1 mutations correlate with reduced p15(INK4B) levels and enhanced hematopoietic progenitor proliferation.
- ASXL1 depletion confers resistance to growth inhibitory signals.
Conclusions:
- ASXL1/BAP1-mediated H2A deubiquitylation is critical for INK4B locus activation.
- ASXL1 acts as a tumor suppressor by regulating INK4B expression through epigenetic mechanisms.
- Dysregulation of ASXL1-dependent deubiquitylation contributes to tumorigenesis in hematological malignancies.
Related Concept Videos
Inheritance of Chromatin Structures
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
Inhibition of Cdk Activity
X-Inactivation
The JAK-STAT Signaling Pathway

